Topics

"An adverse event is any undesirable experience associated with the use of a medical product in a patient."

Definition source:  https://www.fda.gov/safety/reporting-serious-problems-fda/what-serious-adverse-event 

 

 

‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
"Coronavirus genetic vaccines" are dangerous gene therapies sold with lies
1 in 6 Germans Experienced COVID Vaccine Side Effects, Survey Finds
400,000 Cases of COVID Vaccine Injuries Found in Data Analyzed by German Health Insurer
5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received through 28-FEB-2021
A case of fatal multi-organ inflammation following COVID-19 vaccination
A cautionary note: Toxicity of polyethylene glycol 200 injected intraperitoneally into mice
A Critical Analysis of All-Cause Deaths during COVID-19 Vaccination in an Italian Province
A Pediatric Case of Sensory Predominant Guillain-Barré Syndrome Following COVID-19 Vaccination
A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 Vaccination
A Potential Role of the Spike Protein in Neurodegenerative Diseases: A Narrative Review
A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products
A review of neurological side effects of COVID-19 vaccination
A Systematic Review of Autopsy Findings in Deaths after COVID-19 Vaccination
A Systematic Review of COVID-19 Vaccine-Induced Takotsubo Cardiomyopathy: A 2023 Update
A web‑based genome‑wide association study reveals the susceptibility loci of common adverse events following COVID‑19 vaccination in the Japanese population
A Young Child Died During Moderna COVID Vaccine Clinical Trial — Did FDA Know?
Abnormal Clots and All-Cause Mortality During the Pandemic Experiment: Five Doses of COVID-19 Vaccine Are Evidently Lethal to Nearly All Medicare Participants
Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning
Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines
Acute extensive pulmonary embolism after mRNA SARS-CoV-2 immunization
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination
Acute transverse myelitis after BNT162b2 vaccination against COVID-19: Report of a fatal case and review of the literature
Acute Vertigo After COVID-19 Vaccination: Case Series and Literature Review
Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
AFTER ACTION REVIEW OF THE COVID-19 PANDEMIC: The Lessons Learned and a Path Forward
Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
Age-stratified COVID-19 vaccine-dose fatality rate for Israel and Australia
All Cause Mortality and COVID-19 Injections: Evidence from 28 Weeks of Public Health England “COVID-19 Vaccine Surveillance Reports”
Alternate mechanisms of mRNA vaccine toxicity: which one is the main culprit?
An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine
An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations
Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines
Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries
Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy
Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches
Anecdotals (documentary)
Anti-recoverin Antibody-Associated Post-acute COVID Vaccination Syndrome After BNT162b2 in HLA-B27-Positive Spondylarthritis: A Case Report
Anti-science case study: COVID-19 vaccines’ effectiveness and safety exaggerated
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
APPENDIX 2.2: Cumulative and Interval Summary Tabulation of Serious and Non-Serious Adverse Reactions from Post-Marketing Data Sources
Assessment of cardiac adverse events following COVID‑19 vaccination by speckle tracking echocardiography
Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients
Assessment report: COVID-19 Vaccine Moderna
Association of Guillain-Barré syndrome following COVID-19 vaccination
1007